Association of control and risk of severe asthma-related events in severe or difficult-to-treat asthma patients

被引:69
|
作者
Sullivan, S. D.
Wenzel, S. E.
Bresnahan, B. W.
Zheng, B.
Lee, J. H.
Pritchard, M.
Kamath, T. V.
Weiss, S. T.
机构
[1] Univ Washington, Pharmaceut Outcomes Res & Policy Program, Dept Pharm, Seattle, WA 98195 USA
[2] Univ Pittsburgh, Med Ctr, Div Pulm Allergy & Crit Care Med, Sch Med, Pittsburgh, PA USA
[3] Genentech Inc, San Francisco, CA 94080 USA
[4] Ovat Res Grp, San Francisco, CA USA
[5] Brigham & Womens Hosp, Channing Lab, Dept Med, Boston, MA 02115 USA
[6] Harvard Univ, Sch Med, Boston, MA 02115 USA
关键词
asthma control; Asthma Therapy Assessment Questionnaire; healthcare utilization; severe asthma;
D O I
10.1111/j.1398-9995.2007.01383.x
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Clinical tools for predicting poor outcomes in asthma patients are lacking. This study investigated the association of asthma control and subsequent severe asthma-related healthcare events in The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study. Methods: The extent of asthma control problems was determined from baseline values of the Asthma Therapy Assessment Questionnaire (ATAQ). Patients self-reported the presence of severe asthma-related events at 6- and 12-month follow up. Poisson regression models determined the adjusted association between baseline control and the likelihood of severe asthma-related events. Results: At baseline, 2942 patients (mean age, 49.6 years; female, 71.9%) had an ATAQ score (no control problems, 17.0%; 1 control problem, 20.0%; 2 control problems, 30.8%; 3 or 4 control problems, 32.2%) and at least one severe asthma-related event. After adjustment, subjects with three or four control problems were at greater risk for unscheduled office visits [relative risk (RR) = 2.8; 95% confidence interval (CI): 2.4-3.2], course of oral steroids (RR = 2.9; 95% CI: 2.5-3.3), emergency room visits (RR = 4.1; 95% CI: 2.7-6.2) or hospitalization (RR = 13.6; 95% CI: 7.4-24.9), vs no control problems. Progressively poorer levels of asthma control are associated with increasing risk of severe asthma-related events. Conclusions: This study provides evidence of an association between poor asthma control and future severe asthma-related healthcare events. A validated questionnaire may help clinicians identify patients requiring intervention to prevent future severe asthma-related events.
引用
收藏
页码:655 / 660
页数:6
相关论文
共 50 条
  • [31] ASTHMA EXACERBATIONS AND TRIGGERS IN CHILDREN WITH SEVERE/DIFFICULT-TO-TREAT ASTHMA: IMPACT ON QUALITY OF LIFE
    Luskin, A.
    Haselkorn, T.
    Rosen, K.
    Mink, D.
    Chipps, B.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (05) : S6 - S7
  • [32] Aspirin sensitivity and severity of asthma: Evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma
    Mascia, K
    Haselkorn, T
    Deniz, YM
    Miller, DP
    Bleecker, ER
    Borish, L
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2005, 116 (05) : 970 - 975
  • [33] Recent asthma exacerbations predict future exacerbations in children with severe or difficult-to-treat asthma
    Haselkorn, Tmirah
    Zeiger, Robert S.
    Chipps, Bradley E.
    Mink, David R.
    Szefler, Stanley J.
    Simons, F. Estelle R.
    Massanari, Marc
    Fish, James E.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 124 (05) : 921 - 927
  • [34] Problematic Asthma: Risk Factors for the Persistence of Symptoms and Assessment of Features Distinguishing Difficult-to-Treat from Severe Asthma
    Negro, V
    [J]. PEDIATRIC PULMONOLOGY, 2018, 53 : S144 - S144
  • [35] Activity and School Impairment By EPR-3 Asthma Control Guidelines in Children with Severe or Difficult-to-Treat Asthma
    Bacharier, Leonard B.
    Covar, Ronina A.
    Haselkorn, Tmirah
    Iqbal, Ahmar
    Mink, David R.
    Chen, Hubert
    Zeiger, Robert S.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : AB101 - AB101
  • [36] Assessing productivity loss and activity impairment in severe or difficult-to-treat asthma
    Chen, Hubert
    Blanc, Paul D.
    Hayden, Mary L.
    Bleecker, Eugene R.
    Chawla, Anita
    Lee, June H.
    [J]. VALUE IN HEALTH, 2008, 11 (02) : 231 - 239
  • [37] High prevalence of skin test positivity in severe or difficult-to-treat asthma
    Haselkorn, Tmirah
    Borish, Larry
    Miller, Dave P.
    Weiss, Scott T.
    Wong, Dennis A.
    [J]. JOURNAL OF ASTHMA, 2006, 43 (10) : 745 - 752
  • [38] The response to combination therapy treatment regimens in severe/difficult-to-treat asthma
    Campbell, J. D.
    Borish, L.
    Haselkorn, T.
    Rasouliyan, L.
    Lee, J. H.
    Wenzel, S. E.
    Sullivan, S. D.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2008, 32 (05) : 1237 - 1242
  • [39] Extent, patterns, and burden of uncontrolled disease in severe or difficult-to-treat asthma
    Sullivan, S. D.
    Rasouliyan, L.
    Russo, P. A.
    Kamath, T.
    Chipps, B. E.
    [J]. ALLERGY, 2007, 62 (02) : 126 - 133
  • [40] Difficult-to-treat and severe asthma in adults Towards a new treatment paradigm
    Meyers, Josh
    Yoo, Jeannie
    Reddel, Helen
    [J]. AUSTRALIAN JOURNAL OF GENERAL PRACTICE, 2019, 48 (04) : 188 - 192